Since 16 January 2021, India has administered more than 1.24 billion doses of COVID-19 vaccines. As of 30
November 2021, India has administered more than 1.3 billion doses overall, including the first and second doses of currentlyapproved vaccines. Oxford–AstraZeneca vaccine (manufactured under license by Serum Institute of India under the trade name
Covishield) and Covaxin (developed locally by Bharat Biotech) were initially approved by India
